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Summary 8 
A fourteen year old domestic shorthair cat was presented because of vomiting, 9 
anorexia and an abdominal mass. A diagnosis could not be made pre operative and 10 
in surgery the mass was assigned to the gastric part of the pancreas. A partial 11 
pancreatectomy and splenectomy was performed using a Ligasure® vessel sealing 12 
device. No surgery related complications occurred. Histological examination revealed 13 
an anaplastic carcinoma of the pancreas. The cat was in a good clinical condition 14 14 
days after surgery. After two months the private vet euthanized the cat with the 15 
suspicion of a pathologic fracture. Review of the xray suggested a bone tumor but 16 
histology was not performed to confirm that. Findings in this case indicated that 17 
pancreatic carcinoma in cats has a poor prognosis a previously described, but 18 
pancreatectomy can be performed as known in dogs and humans using a bipolar 19 
vessel sealing device as a safer and faster alternative to standard surgical 20 
techniques. 21 
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Partielle Pankrektomie und Splenektomie mittels Ligasure bei der 32 
Katze mit einem pankreatischen anaplastischen Karzinom 33 
 34 
 35 
Zusammenfassung 36 
Im Notdienst wurde eine 14 jährige europäisch Kurzhaarkatze mit vorberichtlichem 37 
Erbrechen und Anorexie vorgestellt. In der klinischen Untersuchung und im 38 
Ultraschall wurde eine abdominale Masse palpiert bzw. dargestellt, die präoperativ 39 
nicht näher spezifiziert werden konnte und intraoperativ dem Pankreas zugeordnet 40 
wurde. Eine partielle Pankrektomie mittels einem bipolaren 41 
Gefässversiegelungsgerät (Ligasure ®) verlief ohne Komplikationen und die Katze 42 
zeigte ein gutes Allgemeinbefinden 14 Tage nach der Operation. Histologisch konnte 43 
ein Pankreaskarzinom diagnostiziert werden. Weitere 2 Monate später wurde die 44 
Katze mit Verdacht auf eine pathologische Fraktur eingeschläfert, ohne dass dies 45 
histologisch untersucht wurde. Dieser Fallbericht unterstreicht die schlechte 46 
Prognose von Pankreaskarzinomen bei Katzen und zeigt die partielle Pankrektomie 47 
mittels Ligasure® als schnelle und sichere Alternative zu konventionellen Techniken 48 
bei der Katze. 49 
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 64 
Introduction 65 
Cancer of the exocrine pancreas is very rare in dogs and uncommon in cats 66 
(Davenport, 1985). Most pancreas cancer in cats are adenocarcinomas of ductular or 67 
acinar origin (Withrow, 2007). The prognosis for these animals is considered poor 68 
and metastases, usually to liver, lymph nodes or the lungs, are often widespread at 69 
the time of diagnosis (Bennett, 1997; Thomson, 2003). The use of bipolar 70 
electrosurgical vessel sealing devices is becoming more and more common both in 71 
human and veterinary medicine for a variety of surgical procedures. These include 72 
partial pancreatectomy in dogs and humans (Hartwig et al., 2010; Wouters et al., 73 
2011), laparoscopic ovariectomy in dogs and horses (Hand et al., 2002; Mayhew and 74 
Brown, 2007; Dupré et al., 2009), splenectomy in dogs (River and Monnet, 2010), 75 
resection of elongated soft palate (Bredecka et al., 2008) and partial hepatectomy in 76 
dogs (Risselada et al., 2010). To the authors’ knowledge, their use in cats has thus 77 
far not been described. The present report documents the successful removal of a 78 
pancreatic carcinoma with partial pancreatectomy and total splenectomy using a 79 
bipolar vessel sealing device in a cat. 80 
 81 
Clinical examination and diagnosis 82 
A 14-year-old female spayed domestic shorthair cat was referred to the veterinary 83 
hospital with a two-day history of vomiting, apathy and anorexia. The cat was 84 
diagnosed with diabetes mellitus four years prior to presentation and had been in 85 
remission until one month ago when insulin therapy was reinstituted. 86 
 The cat was in a lethargic condition and the abdominal palpation revealed 87 
discomfort and a cranial abdominal mass of approximately 4cm diameter. The 88 
remaining was unremarkable. A complete blood count, serum biochemistry, 89 
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fructosamin and urinalysis revealed leukopenia (leukocytes 3.8 x109/l; reference 90 
range 4.6-12.8 x109/l), hyperglycemia (glucose 25.6 mmol/l; RR 4.0-9.0 mmol/l), 91 
hypoproteinemia (total protein 58 g/l; RR 64-80 g/l), a mildly elevated serum lipase 92 
(116 U/l; RR 8-26 U/l), elevated serum fructosamin (481 µmol/l; RR 202-299 µmol/l), 93 
and glucosuria. Serum fructosamin was elevated. Abdominal ultrasound revealed a 94 
hypoechoic space-occupying mass (3.5cm x 3cm) in contact to the hilus of the 95 
spleen and moderately enlarged lymph nodes in the iliocaecal region (Fig 1). The 96 
liver appeared hypoechoic. Cytology of the mass and the lymph nodes, collected by 97 
ultrasound-guided fine-needle aspiration were not diagnostic and exploratory surgery 98 
was performed. 99 
Surgical Procedure 100 
 A standard midline exploratory coeliotomy was performed and a mass close to 101 
the hilus of the spleen, originating from the left pancreatic lobe, was encountered. A 102 
partial pancreatectomy including removal of the spleen was accomplished using a 103 
bipolar vessel sealing device (Ligasure® 5mm controlled by ForceTriad® Energy 104 
Platform, Covidien, Bolder, CO, USA). Vascularisation of the remaining pancreas 105 
was spared (Fig. 2) and a margin to the mass of approximately 3 cm was respected. 106 
The Ligasure® was applied without any previous dissection by sealing the short 107 
gastric vessels, the splenic artery and vein and the gastroepiploic artery and vein 108 
including partial removal of the omentum. Biopsies were taken from gastric and 109 
iliocaecal lymph nodes and the liver. 110 
 The abdomen was subsequently lavaged with warmed lactated Ringer’s 111 
solution before routine abdominal closure following a total surgical time of 65 112 
minutes. Histological examination of the resected pancreatic segment revealed a 113 
poorly-differentiated carcinoma that was completely excised with clean margins. 114 
Hepatic and lymph node biopsies did not show any evidence of metastasis. 115 
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 116 
Recovery and further examination 117 
 The cat made a satisfactory recovery from the surgery and was discharged 7 118 
days postoperatively. Follow-up examination performed 2 weeks after surgery was 119 
unremarkable and no evidence of abdominal effusion was found either on palpation 120 
or ultrasonographically. Further bloodwork to assure diabetes control and 121 
chemotherapy using gemcitabine (cytostatic cytidine analogue leading to apoptosis) 122 
were declined by the owner. Two months after surgery, the cat was presented to the 123 
referring veterinarian with acute hindlimb lameness. Radiographs of the left femur 124 
revealed a supracondylar short oblique simple femur fracture with a moth-eaten 125 
appearance of the bone. Thoracic laterolateral and ventrodorsal radiographs did not 126 
show evidence of pulmonary metastasis at that time. A pathologic fracture was 127 
suspected and the cat was euthanized at the owner’s request. Post-mortem 128 
examination was declined by the owner. 129 
 130 
Discussion 131 
The presented case documents the successful removal of a pancreatic mass 132 
and the spleen using a bipolar vessel sealing device in a cat. No surgical 133 
complications were encountered and the cat recovered uneventfully from surgery. It 134 
has been shown in pigs that postoperative markers for pancreatitis were lower using 135 
the bipolar vessel sealing device (Hartwig et al., 2010). The seal of the pancreatic 136 
tissue, the less handling necessary for separation of the pancreatic tissue, the 137 
reduced surgical time and the decreased thermal damage compared to conventional 138 
devices results in less risk of postoperative complications (Kennedy et al., 1999; 139 
Stranahan et al., 1999; Goldstein et al., 2002; Wouters et al., 2011).  140 
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Surgical alternatives to the use of this device include partial pancreatectomy 141 
performed by suture fracture technique or dissection ligation (Allen et al.,1989). 142 
Complete removal of the spleen was performed because adhesions between the 143 
tumour and the spleen were present. Preservation of the spleen was considered 144 
impossible without risking damage of the splenic artery and vein and was considered 145 
necessary to achieve clean margins for the resection of the tumor. Little is known 146 
about the outcome in splenectomies performed in cats. One study found preoperative 147 
weight loss to be associated with outcome (3 vs 293 days median survival time) in 148 
feline patients with splenectomy. Even though all of these had splenic masses, 149 
mostly Mastocytoma, and survival is most likely to be associated with the splenic 150 
mass rather than with the splenectomy itself. In the presented case the primary tumor 151 
was pancreatic and the splnectomy was performed because of adhesions so direct 152 
comparison may be difficult (Gordonet al., 2010). 153 
 Two to three separated sealing procedures next to each other for artery and 154 
vein are recommended for splenectomy in dogs weighing up to 66 kg using the 155 
Ligasure® to achieve a secure seal (Rivier and Monnet, 2010). In the cat as reported 156 
here, only one seal and dissecting step was performed without evidence of intra- or 157 
postoperative hemorrhage. It was considered safe and time saving. However, 158 
general recommendations for splenectomy in cats using this device cannot be made 159 
based on a single case. In humans, recommendations regarding the use of 160 
Ligasure® for splenectomy do not include the separation of vein and artery and 161 
multiple sealing steps (Romano et al., 2002; Romano et al., 2007). 162 
Considering the smaller size of the patient, the total operative time of 65 163 
minutes in the present report is comparable to a mean of 78 minutes reported for 164 
splenectomies in dogs (Rivier and Monnet, 2010) and 107 minutes for partial 165 
pancreatectomy in dogs (Wouters et al., 2011). In the presented case the decrease 166 
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in surgery time might also be due to the direct seal of artery and vein and the 167 
dissection to separate these two vessels. In humans, decreased operative time is 168 
reported with the use of Ligasure over stapling devices for splenectomy without a  169 
seal of artery and vein (Romano et al., 2007). 170 
 The bipolar vessel sealing device used seals vessels with a different 171 
technique than the commonly used conventional bipolar systems using lower voltage 172 
and higher currents. Compression of the jaws and the heat generated induce fusion 173 
of collagen and elastin in vessel walls and subsequent tissue reformation with 174 
creation of a permanent seal zone (Kennedy et al., 1999; Heniford et al., 2001; 175 
Shamiyeh et al., 2002). The tissue damage is limited because the heat created 176 
reaches only 50-80°C compared to up to 600°C with the electric scalpel. This results 177 
in reduced healing time and lowers the risk for scar tissue formation (Stranahan et 178 
al., 1999). The collateral spread of 0.5-2 mm is achieved by using tissue impedance 179 
measurement, reduced fusing cycle time and tissue desiccation (Kennedy et 180 
al.,1999; Stranahan et al., 1999; Heniford et al., 2001; Goldstein et al., 2002). The 181 
seal created resists three times the normal blood pressure and arteries up to 7mm in 182 
diameter can be securely sealed in humans (Kennedy et al., 1999; Shamiyeh et al., 183 
2002). Another advantage is the feedback control of the Ligasure® that indicates a 184 
complete seal of the vessel by a tone. This is determined by measuring the 185 
impedance of the sealed tissue. In contrast, an incomplete seal is documented by an 186 
alarm tone giving the surgeon the opportunity to apply the jaws properly and avoiding 187 
severe bleeding due to an incomplete seal. The use of Ligasure® has improved 188 
several procedures in human medicine by creating faster healing time, shorter 189 
hospitalisation periods, less pain and overall lower complication rates (Chiappa et al., 190 
2008; Remzi et al., 2008; Kovacs et al., 2009). In some veterinary procedures, it has 191 
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also been stated to result in faster operating time, less morbidity and shorter 192 
hospitalisation time (Wouters et al., 2011; Rivier and Monnet, 2010). 193 
 Next to the advantages listed above the Ligasure® is an expensive 194 
investment. The control unit is offered for approximately 30.000 SFr and each 195 
instrument is another 500-600 SFr. The instruments are sold as single use devices 196 
but they can be reused after gas sterilization several times. 197 
The use of the Ligasure® appears as a safe and quick technique for splenectomy in 198 
cats. As only one case was presented a prospective comparative study is warranted 199 
to make conclusions generally applicable and to further evaluate the need for 200 
separately sealing artery and vein because this report and the human literature are 201 
contradictionary to the veterinary literature.   202 
 203 
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Figures 208 
Figure 1: Abdominal ultrasound showing the mass adjacent to the otherwise normal  209 
     appearing spleen. 210 
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Figure 2: Dissection of the pancreas with the Ligasure® bipolar vessel sealing  221 
     device.  222 
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 224 
 225 
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